Clinical Trial Update: A Study Designed to Compare 2 Dose Strengths of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin Lispro [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated two dose strengths of TI Inhalation Powder (Technosphere insulin) in adults with Type 1 diabetes and compared a 30-unit inhaled dose t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• TI Inhalation Powder (Technosphere insulin)
• insulin lispro (insulin lispro)

Snippet

Sponsor: Mannkind Corporation | Conditions: Diabetes Mellitus: Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2014-10-16